Industrials
Once in a lifetime - designing electrolyser technologies to work reliably with fluctuating renewable power
Reimagining the future
Healthcare
Ready for Net Negative? Minimising Healthcare’s Contribution to Climate Change through Innovation
Healthcare
How is cell and gene therapy innovation adapting to a changing investment landscape? Insights from TTP’s Cell & Gene panel event
Healthcare
Are we entering a new era in point-of-care diagnostic testing?
Industrials
Detect and avoid: how do we make UAVs “uncollidable” without heavy and expensive sensors?
Sensor fusion will be needed to unlock BVLOS, but achieving low SWAP-C is key to take “detect and avoid” to the next level. TTP went back to first principles to work out what is possible with different sensors.
Industrials
Scalability in industrial biomanufacturing: three objectives of better hardware design
Industrial biomanufacturing must forge ahead and invent its own process technology to scale up the production of food and materials.
Industrials
Do we need new standards for quantum technology?
Quantum entanglement is the scientific basis for "quantum 2.0" technologies being developed all over the world. But how do we reduce risk and uncertainty for adopters? Technology standards can help to abstract out the complex science, but it’s crucial not to stifle innovation.
Industrials
How do we make enough green hydrogen to fuel the world?
We need to scale up green hydrogen electrolysers to meet the demands of a net zero world. The first step is to understand the scale of the challenge.
Healthcare
How can you prove 99.9% reliability? A challenge in automating and scaling cell therapies
As cell and gene therapies become more mainstream, how can – and should – the industry assure the reliability of the therapy manufacturing equipment?
Healthcare
Spatial biology: FISH and sequencing reveal gene expression patterns. Where is the industry now, and what will the future bring?
Spatial sequencing still seems too expensive to match the offer of subcellular resolution and usability of FISH-based technologies outside of the research lab – but with declining costs the value of spatial sequencing could be significant. We see many opportunities for companies to improve their technologies as they look to develop an industry-leading platform.
Healthcare
Translating spatial biology into tissue diagnostics with inventive technology
Diagnostic applications of spatial, multi-omic tissue analysis are emerging. Now we need new technologies to support the field of tissue pathology in making these insights available to clinicians caring for millions of patients.
Industrials
Hydrogen: How do we keep track of the leakiest gas of all?
The need for hydrogen gas sensing is growing beyond its historic focus on leak detection to encompass a broader range of opportunities including blending, process control and metering. Is there one technology that can meet each of these very different opportunities?
Healthcare
Personalising neurostimulation in chronic pain management: tapping into the patient experience when we can’t measure pain
Nerve stimulation therapies for chronic pain can be very successful. But patients and clinicians face day-to-day challenges in the delivery of therapy that call for greater personalisation. Adaptive stimulation paradigms based on neural sensing data could help to achieve this – and give us additional insights.
Healthcare
Next-generation sample preparation: Will better nucleic acid extraction unleash biotechnology, life sciences and diagnostics?
Much is to be gained from developing next-generation sample preparation techniques to keep up with progress in DNA sequencing technology.
